Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro ; volume:26 ; number:5 ; day:4 ; month:9 ; year:2024 ; pages:1-17 ; date:10.2024
The AAPS journal / American Association of Pharmaceutical Scientists ; 26, Heft 5 (4.9.2024), 1-17, 10.2024
- Urheber
-
Lee, David
Shen, Andrew M.
Garbuzenko, Olga B.
Minko, Tamara
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1208/s12248-024-00967-x
- URN
-
urn:nbn:de:101:1-2412172116252.389424657991
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, David
- Shen, Andrew M.
- Garbuzenko, Olga B.
- Minko, Tamara
- SpringerLink (Online service)
Ähnliche Objekte (12)
Studies on the skin penetration mechanisms of liposomal formulations
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Development of siRNA formulations based on cationic and biodegradable polymers
Liposomal formulations for the oral delivery of the pharmaceutically active peptide exenatide
Nanoparticles for RNA interference : novel preclinical formulations for SIRNA mediated gene therapy
Oligoaminoamide-based siRNA formulations for folate receptor-directed tumor targeting and gene silencing
Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
NOSE
NOSE
Studies on the skin penetration mechanisms of liposomal formulations
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Development of siRNA formulations based on cationic and biodegradable polymers
Liposomal formulations for the oral delivery of the pharmaceutically active peptide exenatide
Nanoparticles for RNA interference : novel preclinical formulations for SIRNA mediated gene therapy
Oligoaminoamide-based siRNA formulations for folate receptor-directed tumor targeting and gene silencing
Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
NOSE
NOSE
Studies on the skin penetration mechanisms of liposomal formulations
Liposomal vaccine formulations as prophylactic agents: design considerations for modern vaccines
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Development of siRNA formulations based on cationic and biodegradable polymers
Liposomal formulations for the oral delivery of the pharmaceutically active peptide exenatide
Nanoparticles for RNA interference : novel preclinical formulations for SIRNA mediated gene therapy
Oligoaminoamide-based siRNA formulations for folate receptor-directed tumor targeting and gene silencing
Development and characterization of liposomal formulations containing sesquiterpene lactones for the treatment of chronic gout
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
Development and in vitro testing of liposomal gadolinium-formulations for neutron capture therapy of glioblastoma multiforme
NOSE